Correlation Between InMed Pharmaceuticals and Larimar Therapeutics
Can any of the company-specific risk be diversified away by investing in both InMed Pharmaceuticals and Larimar Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InMed Pharmaceuticals and Larimar Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between InMed Pharmaceuticals and Larimar Therapeutics, you can compare the effects of market volatilities on InMed Pharmaceuticals and Larimar Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InMed Pharmaceuticals with a short position of Larimar Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of InMed Pharmaceuticals and Larimar Therapeutics.
Diversification Opportunities for InMed Pharmaceuticals and Larimar Therapeutics
0.43 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between InMed and Larimar is 0.43. Overlapping area represents the amount of risk that can be diversified away by holding InMed Pharmaceuticals and Larimar Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Larimar Therapeutics and InMed Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InMed Pharmaceuticals are associated (or correlated) with Larimar Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Larimar Therapeutics has no effect on the direction of InMed Pharmaceuticals i.e., InMed Pharmaceuticals and Larimar Therapeutics go up and down completely randomly.
Pair Corralation between InMed Pharmaceuticals and Larimar Therapeutics
Considering the 90-day investment horizon InMed Pharmaceuticals is expected to under-perform the Larimar Therapeutics. In addition to that, InMed Pharmaceuticals is 1.12 times more volatile than Larimar Therapeutics. It trades about -0.27 of its total potential returns per unit of risk. Larimar Therapeutics is currently generating about -0.17 per unit of volatility. If you would invest 801.00 in Larimar Therapeutics on August 27, 2024 and sell it today you would lose (185.00) from holding Larimar Therapeutics or give up 23.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
InMed Pharmaceuticals vs. Larimar Therapeutics
Performance |
| Timeline |
| InMed Pharmaceuticals |
| Larimar Therapeutics |
InMed Pharmaceuticals and Larimar Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with InMed Pharmaceuticals and Larimar Therapeutics
The main advantage of trading using opposite InMed Pharmaceuticals and Larimar Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InMed Pharmaceuticals position performs unexpectedly, Larimar Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Larimar Therapeutics will offset losses from the drop in Larimar Therapeutics' long position.| InMed Pharmaceuticals vs. Quoin Pharmaceuticals Ltd | InMed Pharmaceuticals vs. Allarity Therapeutics | InMed Pharmaceuticals vs. Virax Biolabs Group | InMed Pharmaceuticals vs. Biodexa Pharmaceticals |
| Larimar Therapeutics vs. Vaxcyte | Larimar Therapeutics vs. Syndax Pharmaceuticals | Larimar Therapeutics vs. Merus BV | Larimar Therapeutics vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |